Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Selpercatinib for treating advanced solid tumours with RET gene fusion in people aged 12 years and older Selpercatinib (LOXO-292; LY3527723) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Selumetinib for treating symptomatic, inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in adults Selumetinib (AZD6244; ARRY-142886) Plexiform neurofibromas Neurological Cancer , Neurology 2023 View  |  Download
Semaglutide for non-cirrhotic non-alcoholic steatohepatitis Semaglutide (Ozempic) Non-alcoholic steatohepatitis (NASH) Hepatology 2023 View  |  Download
Semaglutide for treating overweight or obesity with cardiovascular disease Semaglutide (Ozempic) Cardiovascular disease (CVD) , Obesity Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Serplulimab with chemotherapy for treating previously untreated extensive stage small-cell lung cancer Serplulimab (HLX10) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2023 View  |  Download
Sirolimus-eluting collagen implant for preventing vascular access failure in end stage renal disease patients undergoing haemodialysis Sirolimus-eluting collagen implant Renal disease Cardiovascular System , Immunology 2023 View  |  Download
Sparsentan for treating primary IgA nephropathy Sparsentan (RE-021; PS433540) IgA nephropathy Immunology , Nephrology 2023 View  |  Download
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed and/or refractory multiple myeloma Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) , Subcutaneous isatuximab Multiple myeloma (MM) Haematological Cancer and Lymphomas 2023 View  |  Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi) Follicular lymphoma , Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2023 View  |  Download
Tarlatamab for relapsed/refractory small-cell lung cancer Tarlatamab Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications